Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Fulvestrant in Combination With CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current PerspectivesBreast Cancer (Dove Med Press) 2020 Apr 01;2020(12)45-56, M Iorfida, M Mazza, E Munzone
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.